Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects clinical trial (NCT00044577). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this new treatment compare to my current HIV medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects clinical trial (NCT00044577). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of with this new combination?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects clinical trial (NCT00044577). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects clinical trial (NCT00044577). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects clinical trial (NCT00044577). Contact the study team or your healthcare provider for specific answers.

What this study is about